Alterations of a cellular cholesterol metabolism network are a molecular feature of obesity-related type 2 diabetes and cardiovascular disease

Diabetes

Volumn 64, Issue 10, 2015, Pages 3464-3474

  Ding, Jingzhong ^a   Reynolds, Lindsay M ^a   Zeller, Tanja ^b   Müller, Christian ^b   Lohman, Kurt ^a   Nicklas, Barbara J ^a   Kritchevsky, Stephen B ^a   Huang, Zhiqing ^c   De La Fuente, Alberto ^d   Soranzo, Nicola ^e   Settlage, Robert E ^f   Chuang, Chia Chi ^a   Howard, Timothy ^a   Xu, Ning ^g   Goodarzi, Mark O ^g   Chen, Y D Ida ^h   Rotter, Jerome I ^h   Siscovick, David S ⁱ   Parks, John S ^a   Murphy, Susan ^c   Jacobs, David R ^j   Post, Wendy ^k   Tracy, Russell P ^l   Wild, Philipp S ^m   Blankenberg, Stefan ^b   Hoeschele, Ina ^f   Herrington, David ^a   McCall, Charles E ^a   Liu, Yongmei ^a   more..

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

^c DUKE UNIVERSITY   (United States)

^d LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^e CRS4 Bioinformatica ^*  (Italy)

^f VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

^g CEDARS SINAI MEDICAL CENTER   (United States)

^h HARBOR UCLA MEDICAL CENTER   (United States)

ⁱ NEW YORK ACADEMY OF MEDICINE   (United States)

^j UNIVERSITY OF MINNESOTA   (United States)

^k JOHNS HOPKINS UNIVERSITY   (United States)

^l UNIVERSITY OF VERMONT   (United States)

^m JOHANNES GUTENBERG UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; CHOLESTEROL; FARNESYL DIPHOSPHATE FARNESYLTRANSFERASE 1; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE 1; LOW DENSITY LIPOPROTEIN RECEPTOR; METHYLSTEROL MONOOXYGENASE 1; MYOSIN REGULATORY LIGHT CHAIN INTERACTING PROTEIN; PROTEIN; SQUALENE MONOOXYGENASE; SQUALENE SYNTHASE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE; TRANSCRIPTOME;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; GENE DOSAGE; GENE EXPRESSION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RNA SEQUENCE; WEIGHT REDUCTION; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION; HUMANS; MALE; OBESITY; TRANSCRIPTOME; WEIGHT LOSS;

EID: 84956912733     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1314     Document Type: Article

References (53)

1. Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009;6:399-409
2. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808
3. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830
4. Arkan MC, Hevener AL, Greten FR, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005;11:191-198
5. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-867
6. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011;145:341-355
7. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 2010;465:721-727
8. Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871-881
9. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003;100:9440-9445
10. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008;9:559
11. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:3
12. Dunham I, Kundaje A, Aldred SF, et al.; ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74
13. Rosenbloom KR, Sloan CA, Malladi VS, et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res 2013;41:D56-D63
14. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012;13:484-492
15. Rosseel Y. lavaan: an R package for structural equation modeling. J Stat Softw 2012;48:1-36
16. Nicklas BJ, Gaukstern JE, Legault C, Leng I, Rejeski WJ. Intervening on spontaneous physical activity to prevent weight regain in older adults: design of a randomized, clinical trial. Contemp Clin Trials 2012;33:450-455
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419
18. Brown MS, Goldstein JL. Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proc Natl Acad Sci U S A 1979;76:3330-3337
19. Zelcer N, Hong C, Boyadjian R, Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009;325:100-104
20. Flowers MT, Ntambi JM. Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism. Curr Opin Lipidol 2008;19:248-256
21. Glaser C, Heinrich J, Koletzko B. Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metabolism 2010;59:993-999
22. Seth G, McIvor RS, Hu WS. 17Beta-hydroxysteroid dehydrogenase type 7 (Hsd17b7) reverts cholesterol auxotrophy in NS0 cells. J Biotechnol 2006;121:241-252
23. Wang X, Collins HL, Ranalletta M, et al. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest 2007;117:2216-2224
24. Zeller T, Wild P, Szymczak S, et al. Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS One 2010;5:e10693
25. Liu Y, Ding J, Reynolds LM, et al. Methylomics of gene expression in human monocytes. Hum Mol Genet 2013;22:5065-5074
26. Zhao L, Chen Y, Tang R, et al. Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis. J Gastroenterol Hepatol 2011;26:875-883
27. Wang Y, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines. J Lipid Res 2005;46:2377-2387
28. Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004;45:1169-1196
29. Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z. Regulation of lipoprotein trafficking in the kidney: role of inflammatory mediators and transcription factors. Biochem Soc Trans 2004;32:88-91
30. Chen Y, Ku H, Zhao L, et al. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation. Arterioscler Thromb Vasc Biol 2014;34:365-376
31. Mutch DM, Pers TH, Temanni MR, et al.; DiOGenes Project. A distinct adipose tissue gene expression response to caloric restriction predicts 6-mo weight maintenance in obese subjects. Am J Clin Nutr 2011;94:1399-1409
32. Dahlman I, Linder K, Arvidsson Nordström E, et al. Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr 2005;81:1275-1285
33. Johansson LE, Danielsson AP, Parikh H, et al. Differential gene expression in adipose tissue from obese human subjects during weight loss and weight maintenance. Am J Clin Nutr 2012;96:196-207
34. Shea J, French CR, Bishop J, et al. Changes in the transcriptome of abdominal subcutaneous adipose tissue in response to short-term overfeeding in lean and obese men. Am J Clin Nutr 2009;89:407-415
35. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 2002;110:905-911
36. Bie J, Zhao B, Song J, Ghosh S. Improved insulin sensitivity in high fat- and high cholesterol-fed Ldlr-/-mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: role of macrophage inflammation and infiltration into adipose tissue. J Biol Chem 2010;285:13630-13637
37. Bie J, Zhao B, Marqueen KE, Wang J, Szomju B, Ghosh S. Macrophagespecific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice. Am J Physiol Endocrinol Metab 2012;302:E1283-E1291
38. Le Lay S, Ferré P, Dugail I. Adipocyte cholesterol balance in obesity. Biochem Soc Trans 2004;32:103-106
39. Yu BL, Zhao SP, Hu JR. Cholesterol imbalance in adipocytes: a possible mechanism of adipocytes dysfunction in obesity. Obes Rev 2010;11:560-567
40. de Haan W, Bhattacharjee A, Ruddle P, Kang MH, Hayden MR; de. ABCA1 in adipocytes regulates adipose tissue lipid content, glucose tolerance, and insulin sensitivity. J Lipid Res 2014;55:516-523
41. Fryirs M, Barter PJ, Rye KA. Cholesterol metabolism and pancreatic betacell function. Curr Opin Lipidol 2009;20:159-164
42. Maxfield FR, Tabas I. Role of cholesterol and lipid organization in disease. Nature 2005;438:612-621
43. Brunham LR, Kruit JK, Pape TD, et al. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 2007;13:340-347
44. Kennedy MA, Barrera GC, Nakamura K, et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 2005;1:121-131
45. Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol 2013;62:921-925
46. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-887
47. Emilsson V, Thorleifsson G, Zhang B, et al. Genetics of gene expression and its effect on disease. Nature 2008;452:423-428
48. Hulsmans M, Geeraert B, De Keyzer D, et al. Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome. PLoS One 2012;7:e30414
49. Feinberg AP, Irizarry RA, Fradin D, et al. Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci Transl Med 2010;2:49ra67
50. Zhong H, Yang X, Kaplan LM, Molony C, Schadt EE. Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am J Hum Genet 2010;86:581-591
51. Dimas AS, Deutsch S, Stranger BE, et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009;325:1246-1250
52. Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011;11:762-774
53. Varela LM, Ortega A, Bermudez B, et al. A high-fat meal promotes lipid-load and apolipoprotein B-48 receptor transcriptional activity in circulating monocytes. Am J Clin Nutr 2011;93:918-925